These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7856070)

  • 1. An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases.
    Dua N; Reubel G; Moore PF; Higgins J; Pedersen NC
    Vet Immunol Immunopathol; 1994 Nov; 43(4):337-55. PubMed ID: 7856070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.
    Pedersen NC; Leutenegger CM; Woo J; Higgins J
    Vet Immunol Immunopathol; 2001 May; 79(1-2):53-67. PubMed ID: 11356250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity.
    Hohdatsu T; Miyagawa N; Ohkubo M; Kida K; Koyama H
    Arch Virol; 2000; 145(12):2525-38. PubMed ID: 11205103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats.
    Reubel GH; George JW; Barlough JE; Higgins J; Grant CK; Pedersen NC
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):95-119. PubMed ID: 1363011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain.
    Kohmoto M; Uetsuka K; Ikeda Y; Inoshima Y; Shimojima M; Sato E; Inada G; Toyosaki T; Miyazawa T; Doi K; Mikami T
    J Vet Med Sci; 1998 Mar; 60(3):315-21. PubMed ID: 9560779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
    Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
    Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.
    Eckstrand CD; Hillman C; Smith AL; Sparger EE; Murphy BG
    PLoS One; 2016; 11(1):e0146285. PubMed ID: 26741651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B.
    Phadke AP; de la Concha-Bermejillo A; Wolf AM; Andersen PR; Baladandayuthapani V; Collisson EW
    Vet Microbiol; 2006 Jun; 115(1-3):64-76. PubMed ID: 16574348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
    Hayes KA; Lafrado LJ; Erickson JG; Marr JM; Mathes LE
    J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):127-34. PubMed ID: 8381867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.
    Sprague WS; Troyer RM; Zheng X; Wood BA; Macmillian M; Carver S; VandeWoude S
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.
    Onanga R; Kornfeld C; Pandrea I; Estaquier J; Souquière S; Rouquet P; Mavoungou VP; Bourry O; M'Boup S; Barré-Sinoussi F; Simon F; Apetrei C; Roques P; Müller-Trutwin MC
    J Virol; 2002 Oct; 76(20):10256-63. PubMed ID: 12239301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.
    Crawford PC; Papadi GP; Levy JK; Benson NA; Mergia A; Johnson CM
    J Infect Dis; 2001 Sep; 184(6):671-81. PubMed ID: 11517427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
    Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
    J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of CD8(+) T cell anti-feline immunodeficiency virus activity correlated with peripheral CD4(+) T cell counts and plasma viremia.
    Hohdatsu T; Yamazaki A; Yamada M; Kusuhara H; Kaneshima T; Koyama H
    Microbiol Immunol; 2003; 47(10):765-73. PubMed ID: 14605443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
    Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of proviruses and viral RNA in the early stages of feline immunodeficiency virus infection in cats: a possible model of the early stage of HIV infection.
    Ohkura T; Shin YS; Wakamiya N; Iwa N; Kurimura T
    Exp Anim; 1997 Jan; 46(1):31-9. PubMed ID: 9027469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
    Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
    AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.